Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
Authors
Keywords
-
Journal
Stem Cell Reviews and Reports
Volume 8, Issue 3, Pages 994-1010
Publisher
Springer Nature
Online
2012-01-25
DOI
10.1007/s12015-011-9344-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
- (2011) Anat Eldar-Boock et al. BIOMATERIALS
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The ABCG2 resistance network of glioblastoma
- (2011) Anne-Marie Bleau et al. CELL CYCLE
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Drug transporters of platinum-based anticancer agents and their clinical significance
- (2011) Herman Burger et al. DRUG RESISTANCE UPDATES
- MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2
- (2011) Qiuhua Wu et al. GYNECOLOGIC ONCOLOGY
- Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
- (2011) Enfeng Wang et al. PLoS One
- Specific Unsaturated Fatty Acids Enforce the Transdifferentiation of Human Cancer Cells toward Adipocyte-like Cells
- (2011) Antonio Ruiz-Vela et al. Stem Cell Reviews and Reports
- Clinical significance of side population in ovarian cancer cells
- (2011) Shinji Hosonuma et al. Human Cell
- Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
- (2011) Karina Dahl Steffensen et al. Journal of Oncology
- Dynamic emergence of the mesenchymal CD44posCD24neg/low phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)
- (2010) Cristina Oliveras-Ferraros et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate
- (2010) X. Jiang et al. BLOOD
- Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma
- (2010) Guo-Fen Yang et al. BMC CANCER
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
- (2010) David G. DeNardo et al. CANCER AND METASTASIS REVIEWS
- Cancer stem cells and chemoradiation resistance
- (2010) Hideshi Ishii et al. CANCER SCIENCE
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
- (2010) Roberta Pang et al. Cell Stem Cell
- Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions
- (2010) Sivan Elloul et al. CLINICAL & EXPERIMENTAL METASTASIS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Unmasking the complexities of mucinous ovarian carcinoma
- (2010) Michael Frumovitz et al. GYNECOLOGIC ONCOLOGY
- Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer
- (2010) Stefania Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy
- (2010) Xi-wei Ding et al. LIFE SCIENCES
- Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?
- (2010) Mahendra P. Deonarain et al. mAbs
- Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours
- (2010) Vitaly Sviatoha et al. MELANOMA RESEARCH
- Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells
- (2010) J. M. Angelastro et al. MOLECULAR CANCER RESEARCH
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemical features of CD133 expression: Association with resistance to chemoradiotherapy in rectal cancer
- (2010) Saigusa ONCOLOGY REPORTS
- Pharmacogenomics of paclitaxel
- (2010) Cristina Rodríguez-Antona PHARMACOGENOMICS
- Human Endometrial Side Population Cells Exhibit Genotypic, Phenotypic and Functional Features of Somatic Stem Cells
- (2010) Irene Cervelló et al. PLoS One
- Human ovarian cancer stem cells
- (2010) Sharmila A Bapat REPRODUCTION
- Small-molecule delivery by nanoparticles for anticancer therapy
- (2010) Zhuo (Georgia) Chen TRENDS IN MOLECULAR MEDICINE
- Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer
- (2009) Yu-Chih Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification and targeting of cancer stem cells
- (2009) Tobias Schatton et al. BIOESSAYS
- Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties
- (2009) C Hegedűs et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- Aldehyde Dehydrogenase-Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
- (2009) J. E. Carpentino et al. CANCER RESEARCH
- MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
- (2009) R. Bhattacharya et al. CANCER RESEARCH
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
- (2009) Koji Morimoto et al. CANCER SCIENCE
- The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells
- (2009) Hiroaki Kajiyama et al. CANCER SCIENCE
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
- (2009) X.-R. Yang et al. CLINICAL CANCER RESEARCH
- Pharmacogenomics of platinum-based chemotherapy in NSCLC
- (2009) Michelle AT Hildebrandt et al. Expert Opinion on Drug Metabolism & Toxicology
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Ovarian carcinoma pathology and genetics: recent advances
- (2009) C. Blake Gilks et al. HUMAN PATHOLOGY
- CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
- (2009) Sung Pil Hong et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
- (2009) Alexei V. Salnikov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
- (2009) Anthony L.A. Fields et al. JOURNAL OF CLINICAL ONCOLOGY
- EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
- (2009) Benoit Terris et al. JOURNAL OF HEPATOLOGY
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- Overexpression of CD24, c-myc and Phospholipase 2A in Prostate Cancer Tissue Samples Obtained by Needle Biopsy
- (2009) Balint Nagy et al. PATHOLOGY & ONCOLOGY RESEARCH
- Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression
- (2009) Pedro C Lara et al. Radiation Oncology
- Management of Women With Newly Diagnosed Ovarian Cancer
- (2009) Carolyn Krasner et al. SEMINARS IN ONCOLOGY
- Surgical Management of Recurrent Ovarian Cancer
- (2009) Mario M. Leitao et al. SEMINARS IN ONCOLOGY
- Building a Framework for Embryonic Microenvironments and Cancer Stem Cells
- (2009) Antonio Ruiz-Vela et al. Stem Cell Reviews and Reports
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- Ovarian Cancer: A Clinical Challenge That Needs Some Basic Answers
- (2009) Kate Lawrenson et al. PLOS MEDICINE
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- Endometrioid epithelial ovarian cancer
- (2008) Dawn J. Storey et al. CANCER
- Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
- (2008) Zhen Fan Yang et al. CANCER CELL
- Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer
- (2008) Sang Joon Shin et al. CANCER LETTERS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Cancer induction by restriction of oncogene expression to the stem cell compartment
- (2008) María Pérez-Caro et al. EMBO JOURNAL
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
- (2008) Ralph J Deberardinis GENETICS IN MEDICINE
- In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
- (2008) Walter H. Gotlieb et al. GYNECOLOGIC ONCOLOGY
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic Melanoma
- (2008) Germana Rappa et al. STEM CELLS
- Expression of CD24 in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance
- (2008) Hyun Ju Lee et al. UROLOGY
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started